- Home
- BCDA vs VEEE Comparison
BCDA vs VEEE Comparison
Compare BCDA & VEEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCDA
- VEEE
- Stock Information
- Founded
- BCDA N/A
- VEEE 1994
- Country
- BCDA United States
- VEEE United States
- Employees
- BCDA N/A
- VEEE N/A
- Industry
- BCDA Biotechnology: Pharmaceutical Preparations
- VEEE Marine Transportation
- Sector
- BCDA Health Care
- VEEE Industrials
- Exchange
- BCDA Nasdaq
- VEEE Nasdaq
- Market Cap
- BCDA 11.3M
- VEEE 5.8M
- IPO Year
- BCDA N/A
- VEEE 2021
- Fundamental
- Price
- BCDA $1.54
- VEEE $2.36
- Analyst Decision
- BCDA Strong Buy
- VEEE
- Analyst Count
- BCDA 1
- VEEE 0
- Target Price
- BCDA $25.00
- VEEE N/A
- AVG Volume (30 Days)
- BCDA 94.6K
- VEEE 4.4M
- Earning Date
- BCDA 11-12-2025
- VEEE 11-13-2025
- Dividend Yield
- BCDA N/A
- VEEE N/A
- EPS Growth
- BCDA N/A
- VEEE N/A
- EPS
- BCDA N/A
- VEEE N/A
- Revenue
- BCDA N/A
- VEEE $13,153,262.00
- Revenue This Year
- BCDA N/A
- VEEE N/A
- Revenue Next Year
- BCDA N/A
- VEEE N/A
- P/E Ratio
- BCDA N/A
- VEEE N/A
- Revenue Growth
- BCDA N/A
- VEEE N/A
- 52 Week Low
- BCDA $1.54
- VEEE $1.86
- 52 Week High
- BCDA $3.25
- VEEE $9.30
- Technical
- Relative Strength Index (RSI)
- BCDA 29.50
- VEEE 52.92
- Support Level
- BCDA $2.11
- VEEE $2.31
- Resistance Level
- BCDA $2.29
- VEEE $2.62
- Average True Range (ATR)
- BCDA 0.12
- VEEE 0.32
- MACD
- BCDA -0.04
- VEEE 0.02
- Stochastic Oscillator
- BCDA 0.66
- VEEE 31.25
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power boats to use for fishing, diving and water skiing, and commercial activities including transportation, eco-tours, fishing, and diving expeditions. The company offers various boat models, including Twin Vee 400 GFX2 CC, Twin Vee 280 GFX2 CC, and Twin Vee 260 Center Console STX, among others. Its products are marketed under two brands, Twin Vee for its catamarans, or dual-hull vessels, and Aquasport for its V-hull boats. The company sells its boats through a network of independent boat dealers across North America, the Caribbean, and Central America who resell the boats to the end user, Twin Vee customers.